Tag: Novartis
Johnson & Johnson becomes the world’s most valuable pharma brand for...
Johnson & Johnson has claimed the title of the world's most valuable and strongest pharmaceutical brand, according to a new report by Brand Finance, the world’s leading...
Nasal spray market may grow to $16.85 billion by 2031
The Global Nasal Spray Market, valued at $9.21 billion in 2021, is projected to achieve significant growth, reaching $16.85 billion by 2031 at a...
Novartis acquires Chinook Therapeutics for US$ 3.2bn
Switzerland-based pharma major Novartis on 12 June announced that it has entered into an agreement to acquire Chinook Therapeutics, a Seattle-based clinical-stage biopharmaceutical company...
Nod for Hua’s diabetes drug in partnership with Bayer
The recent approval of Hua’s first-in-class diabetes drug in China in collaboration with Bayer puts an end to a decade-long wait for molecules with...
Phase III study for lung cancer treatment did not meet goal...
Healthcare company Novartis has announced that its Phase III of the Canopy-A trial using canakinumab as an additional medicine in treating non-small cell lung...
Early detection and regular treatment are key to managing Heart Failure
Heart failure is the gradual weakening of heart muscle due to which the heart's pumping capacity cannot meet the body's requirements. People often believe...
Novartis discontinues hydroxychloroquine clinical trial
Novartis has decided to stop and discontinue its sponsored hydroxychloroquine (HCQ) clinical trial for Covid-19 due to acute enrollment challenges that have made trial...
Novartis Sandoz terminates sale agreement with Aurobindo
Novartis announced the mutual agreement with Aurobindo Pharma USA to terminate the agreement to sell the Sandoz US generic oral solids and dermatology businesses...
Novartis to donate up to 130 million doses of hydroxychloroquine to...
Novartis announced today its commitment to donate up to 130 million doses of generic hydroxychloroquine to support the global COVID-19 pandemic response. Hydroxychloroquine and...